Cargando…
Review of EGFR TKIs in Metastatic NSCLC, Including Ongoing Trials
Recent clinical trials have demonstrated the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) in the treatment of patients with advanced metastatic non-small cell lung cancer. Most of these recent trials were conducted in patients with EGFR mutation-positive tumor...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164005/ https://www.ncbi.nlm.nih.gov/pubmed/25309870 http://dx.doi.org/10.3389/fonc.2014.00244 |